BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14587640)

  • 1. Usefulness of 1H MR spectroscopy in the evaluation of myocardial metabolism in patients with dilated idiopathic cardiomyopathy: pilot study.
    Walecki J; Michalak MJ; Michalak E; Bilinska ZT; Ruzyllo W
    Acad Radiol; 2003 Oct; 10(10):1187-92. PubMed ID: 14587640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy.
    Nakae I; Mitsunami K; Omura T; Yabe T; Tsutamoto T; Matsuo S; Takahashi M; Morikawa S; Inubushi T; Nakamura Y; Kinoshita M; Horie M
    J Am Coll Cardiol; 2003 Nov; 42(9):1587-93. PubMed ID: 14607443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine depletion and altered fatty acid metabolism in diseased human hearts: clinical investigation using 1H magnetic resonance spectroscopy and 123I BMIPP myocardial scintigraphy.
    Nakae I; Mitsunami K; Matsuo S; Horie M
    Acta Radiol; 2007 May; 48(4):436-43. PubMed ID: 17453526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
    Neubauer S; Horn M; Cramer M; Harre K; Newell JB; Peters W; Pabst T; Ertl G; Hahn D; Ingwall JS; Kochsiek K
    Circulation; 1997 Oct; 96(7):2190-6. PubMed ID: 9337189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
    Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K
    Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
    Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
    J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease.
    Neubauer S; Horn M; Pabst T; Gödde M; Lübke D; Jilling B; Hahn D; Ertl G
    Eur Heart J; 1995 Dec; 16 Suppl O():115-8. PubMed ID: 8682076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.
    Hardy CJ; Weiss RG; Bottomley PA; Gerstenblith G
    Am Heart J; 1991 Sep; 122(3 Pt 1):795-801. PubMed ID: 1877457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy.
    Nakae I; Mitsunami K; Matsuo S; Inubushi T; Morikawa S; Tsutamoto T; Koh T; Horie M
    Circ J; 2005 Jun; 69(6):711-6. PubMed ID: 15914951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial lipids and creatine measured by magnetic resonance spectroscopy among patients with heart failure].
    Winter JL; Castro P; Meneses L; Chalhub M; Verdejo H; Greig D; Gabrielli L; Chiong M; Concepción R; Mellado R; Hernández C; Uribe S; Lavandero S
    Rev Med Chil; 2010 Dec; 138(12):1475-9. PubMed ID: 21526294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy.
    Kalsi KK; Smolenski RT; Pritchard RD; Khaghani A; Seymour AM; Yacoub MH
    Eur J Clin Invest; 1999 Jun; 29(6):469-77. PubMed ID: 10354207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging.
    Auffermann W; Chew WM; Wolfe CL; Tavares NJ; Parmley WW; Semelka RC; Donnelly T; Chatterjee K; Higgins CB
    Radiology; 1991 Apr; 179(1):253-9. PubMed ID: 2006287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?
    Kanzaki Y; Yuki M; Yamamura KI; Narumi Y; Ishizaka N
    Heart Vessels; 2016 Dec; 31(12):1950-1959. PubMed ID: 26897743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.
    Yazaki Y; Isobe M; Takahashi W; Kitabayashi H; Nishiyama O; Sekiguchi M; Takemura T
    Heart; 1999 Feb; 81(2):153-9. PubMed ID: 9922350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy.
    Beadle RM; Williams LK; Kuehl M; Bowater S; Abozguia K; Leyva F; Yousef Z; Wagenmakers AJ; Thies F; Horowitz J; Frenneaux MP
    JACC Heart Fail; 2015 Mar; 3(3):202-11. PubMed ID: 25650370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy.
    Avci A; Alizade E; Fidan S; Yesin M; Guler Y; Kargin R; Esen AM
    Scand Cardiovasc J; 2014 Aug; 48(4):202-8. PubMed ID: 24912526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in myocardial work of the left ventricle in patients with idiopathic dilated cardiomyopathy: Implications for the surgical technique used for left ventriculoplasty.
    Yanagida R; Sugawara M; Kawai A; Koyanagi H
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):600-7. PubMed ID: 11547316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy.
    Beer M; Wagner D; Myers J; Sandstede J; Köstler H; Hahn D; Neubauer S; Dubach P
    J Am Coll Cardiol; 2008 May; 51(19):1883-91. PubMed ID: 18466804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.